Your AI-Powered Market Intelligence

Tuesday, November 10, 2026
RSS



IPO

Anticipation Grows for SpaceX's Maiden Earnings Report and Lock-Up Expiration

SpaceX's first earnings report on August 4 coincides with a critical lock-up expiration, stirring volatility in $SPCX.

Jul 21, 2026
IPO

Surge in Archer Aviation (ACHR) Call Options: A Momentum Play in the Making

A significant spike in call options for Archer Aviation signals heightened trader interest in the eVTOL market.

Jul 21, 2026
IPO

Nebius Group's Game-Changing Move in AI Infrastructure Sparks Trader Interest

Nebius Group (NBIS) makes a significant move in AI infrastructure, capturing trader attention with potential breakout opportunities.

Jul 17, 2026
IPO

NextCure's Reverse Merger with Avere Therapeutics Promises High-Stakes Trading

NextCure's merger with Avere Therapeutics opens up high-volatility trading opportunities in the immunology sector.

Jul 14, 2026
IPO

Whitestone REIT Shareholders Approve Ares Acquisition: Market Implications

Whitestone REIT's shareholders have approved the acquisition by Ares, signaling a pivotal moment for REIT M&A activity.

Jul 10, 2026
IPO

IQM Quantum Computers Makes Historic Nasdaq Debut: What It Means for Investors

IQM Quantum Computers debuts on Nasdaq as the first European quantum company, signaling a new era in the tech market.

Jul 3, 2026
IPO

StablecoinX Makes Nasdaq Debut: A New Era for Crypto Infrastructure

StablecoinX (Nasdaq: USDE) begins trading after merging with TLGY Acquisition Corp. Expect volatility as traders react to this new market en…

Jun 26, 2026
IPO

Biotech Merger Signals Confidence: Boundless Bio and Serapha Bio Join Forces

Boundless Bio and Serapha Bio's merger and $230M placement highlight confidence in rare disease biotech.

Jun 23, 2026
IPO

Columbia Financial and Northfield Bancorp Merger: Shareholder Actions Required

Columbia Financial and Northfield Bancorp are moving forward with their merger, requiring shareholder action on consideration choices.

Jun 12, 2026
IPO

GSK's Bold $10.6 Billion Bet on Nuvalent Signals New Era in Biotech

GSK's $10.6 billion acquisition of Nuvalent marks a significant commitment to oncology and reflects the competitive biotech landscape.

Jun 9, 2026
IPO

TPG and ECHO Realty: A $2B Acquisition Reshaping Grocery-Anchored Retail

TPG leads a $2 billion acquisition of ECHO Realty, highlighting strong interest in stable grocery-anchored retail amid shifting market dynam…

Jun 5, 2026
IPO

Hims & Hers Expands Global Reach with Eucalyptus Acquisition

Hims & Hers is making waves in the telehealth sector with its acquisition of Eucalyptus, targeting key international markets.

Jun 2, 2026